Roivant Sciences authorizes $500M share repurchase program

Roivant Sciences Ltd.

New $500M buyback authorization effective June 24, 2025, in addition to prior $1.5B program now exhausted.
Program has no expiration date; funded from available cash and cash equivalents.
Repurchases may be executed via open market, tender offers, or 10b5-1 trading plans.
Timing and size depend on market price, business conditions, and other investment opportunities.
The program may be suspended or discontinued at any time at the company's discretion.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.